Novozymes A/S's ticker is NVZMY and the CUSIP is 670108109. A total of 19 filers reported holding Novozymes A/S in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $42,000 | +27.3% | 742 | 0.0% | 0.01% | +18.2% |
| Q1 2020 | $33,000 | +6.5% | 742 | +15.6% | 0.01% | +22.2% |
| Q4 2019 | $31,000 | -98.8% | 642 | -98.9% | 0.01% | -98.8% |
| Q3 2019 | $2,565,000 | -11.8% | 60,994 | -2.4% | 0.74% | -14.3% |
| Q2 2019 | $2,907,000 | -0.9% | 62,488 | -2.0% | 0.87% | -5.0% |
| Q1 2019 | $2,934,000 | +1.8% | 63,738 | -1.0% | 0.92% | -5.7% |
| Q4 2018 | $2,882,000 | -24.8% | 64,411 | -8.0% | 0.97% | -14.9% |
| Q3 2018 | $3,834,000 | +11.5% | 70,039 | +2.7% | 1.14% | +3.2% |
| Q2 2018 | $3,439,000 | +2.4% | 68,192 | +7.2% | 1.10% | +2.0% |
| Q1 2018 | $3,360,000 | +0.3% | 63,631 | +8.5% | 1.08% | +6.5% |
| Q4 2017 | $3,349,000 | +31.9% | 58,649 | +18.8% | 1.02% | +16.5% |
| Q3 2017 | $2,540,000 | +70.2% | 49,361 | +44.9% | 0.87% | +44.3% |
| Q2 2017 | $1,492,000 | – | 34,054 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lenox Wealth Management, Inc. | 62,488 | $2,907,000 | 0.87% |
| ZEVIN ASSET MANAGEMENT LLC | 34,899 | $1,624,000 | 0.52% |
| HIGH POINTE CAPITAL MANAGEMENT LLC | 5,090 | $238,000 | 0.33% |
| BOSTON FINANCIAL MANGEMENT LLC | 108,846 | $5,065,000 | 0.29% |
| Moloney Securities Asset Management, LLC | 15,263 | $713,000 | 0.24% |
| Boston Common Asset Management, LLC | 24,577 | $1,148,000 | 0.14% |
| Hemenway Trust Co LLC | 12,125 | $564,000 | 0.09% |
| Renaissance Investment Group LLC | 5,000 | $234,000 | 0.09% |
| QUADRANT CAPITAL GROUP LLC | 5,748 | $263,000 | 0.04% |
| Douglass Winthrop Advisors, LLC | 6,902 | $321,000 | 0.01% |